ANNUAL REPORT 2002
|
|
|
|
|
 |
|
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
BIOPURE CORPORATION
|
| By: |
/s/ FRANCIS H. MURPHY |
|
|
| |
Francis H. Murphy
Chief Financial Officer
|
|
Dated: January 29, 2003
Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report has been
signed below by the following persons on behalf of the Registrant and in the capacities and on the dates
indicated.
| Signature |
|
Title |
|
Date |
|
|
|
|
|
| |
| /s/ CHARLES A. SANDERS, M.D. |
|
| Charles A. Sanders, M.D. |
|
|
Director, Chairman of the Board |
|
January 29, 2003 |
| |
| /s/ DAVID N. JUDELSON |
|
| David N. Judelson |
|
|
Director, Vice Chairman |
|
January 29, 2003 |
| |
| /s/ CARL W. RAUSCH |
|
| Carl W. Rausch |
|
|
Director, Vice Chairman |
|
January 29, 2003 |
| |
| /s/ THOMAS A. MOORE |
|
| Thomas A. Moore |
|
|
Director, President
(Chief Executive Officer) |
|
January 29, 2003 |
| |
| /s/ DANIEL P. HARRINGTON |
|
| Daniel P. Harrington |
|
|
Director |
|
January 29, 2003 |
| |
| /s/ C. EVERETT KOOP, M.D. |
|
| C. Everett Koop, M.D. |
|
|
Director |
|
January 29, 2003 |
| |
| /s/ J. RICHARD CROUT, M.D. |
|
| J. Richard Crout, M.D. |
|
|
Director |
|
January 29, 2003 |
| |
| /s/ FRANCIS H. MURPHY |
|
| Francis H. Murphy |
|
|
Chief Financial Officer,
Principal Accounting Officer |
|
January 29, 2003 |
|
|
|
|